Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Klerfalk Pharma AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 1,083 Less Arrow 1,077 More Arrow 1,598
Financial expenses 3,007 Less Arrow 508 More Arrow 3,028
Earnings before taxes 173 Less Arrow -324 More Arrow 6,635
EBITDA 75 More Arrow 163 More Arrow 591
Total assets 11,859 Less Arrow 11,007 More Arrow 11,806
Current assets 673 More Arrow 1,149 More Arrow 1,645
Current liabilities 373 More Arrow 444 More Arrow 544
Equity capital 11,374 Less Arrow 10,447 More Arrow 11,155
- share capital 51 Less Arrow 47 More Arrow 49
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 95.9% Less Arrow 94.9% Less Arrow 94.5%
Turnover per employee 1,083 Less Arrow 1,077 More Arrow 1,598
Profit as a percentage of turnover 16.0% Less Arrow -30.1% More Arrow 415.2%
Return on assets (ROA) 26.8% Less Arrow 1.7% More Arrow 81.8%
Current ratio 180.4% More Arrow 258.8% More Arrow 302.4%
Return on equity (ROE) 1.5% Less Arrow -3.1% More Arrow 59.5%
Change turnover -71 Less Arrow -473 More Arrow 509
Change turnover % -6% Less Arrow -31% More Arrow 47%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.